pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·4h ago·1 min read
save

Aligned Marketplace secures $20 million to link self-insured employers with primary-care clinics

Aug 13, 2026·read at Endpoints ↗DealPositive

Aligned Marketplace is a health‑tech startup that matches self‑insured employers with primary‑care clinics, helping companies provide direct access to medical services for their workers.

The company announced it has closed a $20 million financing round, according to an exclusive report from Endpoints News. The capital will be used to expand its platform and onboard more clinic partners.

Among its early customers are 7‑Eleven and NextEra Energy, demonstrating interest from both retail and energy sectors in the model. The funding underscores growing investor confidence in solutions that streamline employer‑driven health care.

The new resources are expected to accelerate the rollout of the service, potentially improving primary‑care utilization and cost management for participating employers.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Aligned Marketplace raises $20M to match employers with primary care”

read at Endpoints ↗
91 words · retrieved 4h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoKaryopharm has a month left to salvage its cancer expansion plansEndpoints
  • 3h agoZealand's royalty deal; Khartis raises money for TED drugEndpoints
  • 6h agoTaiho, Cullinan's lung cancer drug passes Phase 3 test, lining up Rybrevant contestEndpoints
  • 7h agoPTC Therapeutics, Lilly to buy up bits of Sangamo in bankruptcy auctionEndpoints
  • 23h agoFour questions on new safety warnings for Neurocrine’s Vykat XREndpoints